Amoxycillin tolerance in helicobacter pylori

Journal of Antimicrobial Chemotherapy

Volumn 43, Issue 1, 1999, Pages 47-54

  Dore, Maria P ^a   Osato, Michael S ^a   Realdi, Giuseppe ^c   Mura, Ida ^c   Graham, David Y ^a   Sepulveda, Antonia R ^a,b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; BETA LACTAMASE;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERICIDAL ACTIVITY; DRUG TOLERANCE; FREEZING; HELICOBACTER PYLORI; NONHUMAN;

AMOXICILLIN; ANTI-BACTERIAL AGENTS; BETA-LACTAM RESISTANCE; FREEZING; HELICOBACTER PYLORI; MICROBIAL SENSITIVITY TESTS; PENICILLIN RESISTANCE; PENICILLINS;

EID: 0032955927     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/43.1.47     Document Type: Article

References (42)

1. Graham, D. Y., Lew, G. M., Klein, P. D., Evans, D. G., Evans, D. J. J., Saeed, Z. A. et al. (1992). Effect of treatment of Helicobacter pylori infection on the long-term recurrence of gastric or duodenal ulcer. A randomized, controlled study. Annals of Internal Medicine 116, 705-8.
2. Peura, D. A. & Graham, D. Y. (1994). Helicobacter pylori: consensus reached: peptic ulcer is on the way to becoming an historic disease. American Journal of Gastroenterology 89, 1137-9.
3. Rauws, E. A. J. & Tytgat, G. N. J. (1990). Cure of duodenal ulcer disease associated with eradication of Helicobacter pylori. Lancet 335, 1233-5.
4. Graham, D. Y., de Boer, W. A. & Tytgat, G. N. (1996). Choosing the best anti-Helicobacter pylori therapy: effect of antimicrobial resistance. American Journal of Gastroenterology 91, 1072-6.
5. van der Hulst, R. W. M., Keller, J. J., Rauws, E. A. & Tytgat, G. N. J. (1996). Treatment of Helicobacter pylori infection: a review of the world literature. Helicobacter 1, 6-19.
6. Bayerdorffer, E., Mannes, G. A., Sommer, A., Hochter, W., Weingart, J., Hatz, R. et al. (1993). Long-term follow-up after eradication of Helicobacter pylori with combination of omeprazole and amoxycillin. Scandinavian Journal of Gastroenterology 28, Suppl. 196, 19-25.
7. Bayerdorffer, E., Miehlke, S., Mannes, G. A., Sommer, A., Hochter, W., Weingart, J. et al. (1995). Double-blind trial of omeprazole and amoxycillin to cure Helicobacter pylori infection in patients with duodenal ulcers. Gastroenterology 108, 1412-7.
8. Dixon, J. S. (1995). Helicobacter pylori eradication: unravelling the facts. Scandinavian Journal of Gastroenterology 30, Suppl. 212, 48-62.
9. Ciociola, A. A., Webb, D. D. & Turner K. (1996). Dual and triple therapy regimens of antisecretory agents and antibiotics for the eradication of Helicobacter pylori: an overview. Scandinavian Journal of Gastroenterology 31, Suppl. 218, 3-9.
10. Soll, A. H. (1996). Consensus conference. Medical treatment of peptic ulcer disease: practice guidelines. Journal of the American Medical Association 275, 622-9.
11. Dore, M. P., Sepulveda, A. R., Mura, I., Realdi, G., Osato, M. S. & Graham, D. Y. (1997). Explanation for variability of omeprazole amoxycillin therapy? Tolerance of H. pylori to amoxycillin. Gastroenterology 112, Abstract A105.
12. Fedorak, R., Archambault, A., Flamm, R., Osato, M. & Stamler, D. (1997). Antimicrobial susceptibility of H. pylori in Canada to three key antibiotics: metronidazole, clarithromycin, and amoxicillin. Gastroenterology 112, Abstract A115.
13. Dore, M. P., Piana, A., Carta, M., Atzei, A., Are, B. M., Mura, I. et al. (1998). Amoxycillin resistance is one reason for failure of amoxycillin omeprazole treatment of Helicobacter pylori infection. Alimentary Pharmacology and Therapeutics, 12, 635-9.
14. Mayhall, C. G. & Apollo, E. (1980). Effect of storage and changes in bacterial growth phase and antibiotic concentrations on antimicrobial tolerance in Staphylococcus aureus. Antimicrobial Agents and Chemotherapy 18, 784-8.
15. Michel, M. F. & van Leeuwen, W. B. (1989). Degree and stability of tolerance to penicilllin in Streptococcus pyogenes. European Journal of Clinical Microbiology and Infectious Diseases 8, 225-32.
16. van Asselt, G. J., de Kort, G. & van de Klundert, J. A. M. (1995). Differences in penicillin-binding protein patterns of penicillin tolerant and non-tolerant group A streptococci. Journal of Antimicrobial Chemotherapy 35, 67-74.
17. Tomasz, A., Albino, A. & Zanati, E. (1970). Multiple antibiotic resistance in a bacterium with suppressed autolytic system. Nature 227, 138-40.
18. Handwerger, S. & Tomasz, A. (1985). Antibiotic tolerance among clinical isolates of bacteria. Reviews of Infectious Diseases 7, 368-86.
19. Tuomanen, E. (1986). Phenotypic tolerance: the search for β-lactam antibiotics that kill nongrowing bacteria. Reviews of Infectious Diseases 8, Suppl. 3, S279-91.
20. Sabath, L. D., Wheeler, N., Lavardiere, M., Blazevic, D. & Wilkinson, B. J. (1977). A new type of penicillin resistance of Staphylococcus aureus. Lancet i, 443-7.
21. Goessens, W. H. F., Fontijne, P., Van Raffe, M. & Michel, M. F. (1984). Tolerance percentage as a criterion for the detection of tolerant Staphylococcus aureus strains. Antimicrobial Agents and Chemotherapy 25, 575-8.
22. Meylan, P. R., Francioli, P. & Glauser, M. P. (1986). Discrepancies between MBC and actual killing of viridans group streptococci by cell-wall active antibiotics. Antimicrobial Agents and Chemotherapy 29, 418-23.
23. Sherris, J. C. (1986). Problems in in vitro determination of antibiotic tolerance in clinical isolates. Antimicrobial Agents and Chemotherapy 30, 633-7.
24. Mendelman, P. M. (1992). Targets of the β-lactam antibiotics, penicillin-binding proteins, in ampicillin-resistant, non-β-lactamase-producing Haemophilus influenzae. Journal of Infectious Diseases 165, Suppl. 1, S107-9.
25. Jain, B., Bender, L., Luck, P. C. & Ott, M. (1992). Ampicillin tolerance of Legionella pneumophila for counter-selection of transconjugates in heterospecific matings with Escherichia coli donors. Journal of Basic Microbiology 32, 423-6.
26. Liu, H. H. & Tomasz, A. (1985). Penicillin tolerance in multiply drug-resistant natural isolates of Streptococcus pneumoniae. Journal of Infectious Diseases 152, 365-72.
27. Kim, K. S. & Anthony, B. F. (1983). Use of penicillin-gradient and replicate plates for the demonstration of tolerance to penicillin in streptococci. Journal of Infectious Diseases 148, 488-91.
28. Siegel, J. D., Shannon, K. M. & DePasse, B. M. (1981). Recurrent infection associated with penicillin-tolerant group B streptococci: a report of two cases. Journal of Pediatrics 99, 920-4.
29. Thometz, J. G., Lamdan, R., Kehl, K. S. & Chusid, M. J. (1996). Microbiological tolerance in orthopaedic infections: delayed response of septic arthritis and osteomyelitis of the hip due to infection with tolerant Staphylococcus aureus. Journal of Pediatric Orthopaedics 16, 518-21.
30. van Asselt, G. J., Mouton, R. P. & van Boven, C. P. (1996). Penicillin tolerance and treament failure in group A streptococcal pharyngotonsillitis. European Journal of Clinical Microbiology and Infectious Diseases 15, 107-15.
31. Betriu, C., Gomez, M., Sanchez, A., Cruceyra, A., Romero, J. & Picazo, J. J. (1994). Antibiotic resistance and penicillin tolerance in clinical isolates of group B streptococci. Antimicrobial Agents and Chemotherapy 38, 2183-6.
32. Orrling, A., Stjernquist-Desatnik, A., Schalen, C. & Kamme, C. (1996). Treatment failure in streptococcal pharyngotonsillitis. An attempt to identify penicillin tolerant Streptococcus pyogenes. Scandinavian Journal of Infectious Diseases 28, 143-7.
33. Hachem, C. Y., Clarridge, J. E., Reddy, R., Flamm, R., Evans, D. G., Tanaka, S. K. et al. (1996). Antimicrobial susceptibility testing of Helicobacter pylori. Comparison of Etest, broth microdilution, and disc diffusion for ampicillin, clarithromycin, and metronidazole. Diagnostic Microbiology and Infectious Diseases 24, 37-41.
34. National Committee for Clinical Laboratory Standards. (1997). Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically - Fourth Edition: Approved Standard M7-A4. NCCLS, Villanova, PA.
35. O'Callaghan, C. H., Morris, A., Kirby, S. & Shingler, A. H. (1972). Novel method for detection of β-lactamase by using a chromogenic cephalosporin substrate. Antimicrobial Agents and Chemotherapy 1, 283-8.
36. Goodwin, C. S., Blake, P. & Blincow, E. (1986). The minimum inhibitory and bactericidal concentrations of antibiotics and anti-ulcer agents against Campylobacter pyloridis. Journal of Antimicrobial Chemotherapy 17, 309-14.
37. Bergeron, M. G. & Lavoie, G. Y. (1985). Tolerance of Haemophilus influenzae to β-lactam antibiotics. Antimicrobial Agents and Chemotherapy 28, 320-5.
38. Haas, C. E., Nix, D. E. & Schentag, J. J. (1990). In vitro selection of resistant Helicobacter pylori. Antimicrobial Agents and Chemotherapy 34, 1637-41.
39. Hirschall, A. M. & Rotter, M. L. (1996). Amoxicillin for the treatment of Helicobacter pylori infection. Journal of Gastroenterology 31, Suppl. 9, 44-7.
40. Best, G. K., Best, N. H. & Koval, A. V. (1974). Evidence for participation of autolysins in bactericidal action of oxacillin on Staphylococcus aureus. Antimicrobial Agents and Chemotherapy 6, 825-30.
41. Denny, A. E., Peterson, L. R., Gerding, D. N. & Hall, W. H. (1979). Serious staphylococcal infections with strains tolerant to bactericidal antibiotics. Archives of Internal Medicine 139, 1026-31.
42. Faville, R. J. J., Zaske, D. E., Kaplan, E. L., Crossley, K., Sabath, L. D. & Quie, P. G. (1978). Staphylococcus aureus endocarditis. Combined therapy with vancomycin and rifampin. Journal of the American Medical Association 240, 1963-5.